SET SMS ALERT
BSE
Jun 22, 09:09
Jun 22, 09:09
610.50
1.95 (+0.32%)
High
611.90
Low
609.80
High
609.40
Low
608.50
Aurobindo Pharma Ltd.
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jun 22, 09:26
606.20
-2.35 (-0.39%)
VOLUME 4,852
AVERAGE VOLUME
| 5-Day | 163,003 |
| 10-Day | 177,575 |
| 30-Day | 128,565 |
VOLUME SHOCKER
| 5-Day | 163,003 |
| 10-Day | 177,575 |
| 30-Day | 128,565 |
Prev. Close
608.55
Open Price
610.50
Bid PRICE (QTY.)
606.30 (3)
Offer PRICE (Qty.)
606.70 (286)
Market
Depth
Depth
Market Depth (22 Jun 2018)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 3 | 606.30 | 606.70 | 286 |
| 9 | 606.20 | 606.75 | 57 |
| 25 | 606.15 | 606.80 | 25 |
| 62 | 605.90 | 606.90 | 295 |
| 524 | 605.85 | 607.00 | 50 |
| 52.12 K | Total | 56.39 K | Total |
Buy Qty
52.12 K
Sell QTY
56.39 K
Today's Low/High
604.00
610.50
52 Wk Low/High
527.05
808.95
L/U Price Band
547.70
669.40
LIVE
NSE
Jun 22, 09:26
606.35
-2.20 (-0.36%)
VOLUME 115,273
AVERAGE VOLUME
| 5-Day | 3,824,147 |
| 10-Day | 3,402,079 |
| 30-Day | 2,575,123 |
VOLUME SHOCKER
| 5-Day | 3,824,147 |
| 10-Day | 3,402,079 |
| 30-Day | 2,575,123 |
Prev. Close
608.55
Open Price
609.40
Bid PRICE (QTY.)
606.30 (18)
Offer PRICE (Qty.)
606.35 (58)
- Quote
- CHARTS
- NEWS
- COMMENTS27 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Track Aurobindo Pharm on the go with the moneycontrol app
Action in Aurobindo Pharma
Aurobindo Pharm
Sentimeter
100%
BUY
100% of moneycontrol users recommend buying Aurobindo Pharm.
What's your call on Aurobindo Pharm today?
Read 27 investor views
Consolidated
MARKET CAP (Rs Cr)
35,517.72
P/E
14.66
BOOK VALUE (Rs)
201.34
DIV (%)
250.00%
Market Lot
1
INDUSTRY P/E
29.43
EPS (TTM)
41.36
P/C
11.91
PRICE/BOOK
3.01
DIV YIELD.(%)
0.41%
FACE VALUE (Rs)
1.00
DELIVERABLES (%)
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
COLLAPSE ALL
Top Trading Ideas
20 June 2018
buy TataElxsi Jun Fut |
Entry Price (Rs) 1,321.00 |
Exit Price (Rs) 1,330.80 |
Gain (Rs) 10.00 |
buy MERCK LTD Jun Fut |
Entry Price (Rs) 2,478.40 |
Exit Price (Rs) 2,635.00 |
Gain (Rs) 157.00 |
F&O Quote
Historic Prices & Simple Moving Averages
Simple Moving Averages
| Days | BSE | NSE |
| 30 | 583.25 | 583.00 |
| 50 | 598.46 | 598.96 |
| 150 | 623.96 | 624.66 |
| 200 | 654.24 | 655.07 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Aurobindo Pharm
The pre-open session lasts for 15 minutes from 9 AM to 9:15 AM and is divided into three parts. In the first 8 minutes orders are placed. These orders can be cancelled or modified during this period. In the next 4 minutes price discovery will be done, and orders will be executed. The remaining 3 minutes are the buffer period to facilitate transition between pre open and continuous trading session.
News/Videos & Announcements
News
Jun 08, 2018
Aurobindo Pharma gets USFDA nod for heartburn drug
Announcements
Jun 08, 2018
Aurobindo Pharma - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jun 06, 2018
Aurobindo Pharma - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Videos
Jun 19, 2018
Jun 15, 2018
Jun 15, 2018
Stock Advice & Research Reports
Stock Advice
Jun 05, 2018
Sell Aurobindo Pharma, target Rs 485: Vinay Rajani
Apr 12, 2018
Buy Aurobindo Pharma, target Rs 680: Achin Goel
Research Reports
Financials
Income Statement
| Standalone | Mar'18 | Dec'17 | Sep'17 | Jun'17 |
| Net Sales | 2,296.32 | 2,620.35 | 2,993.51 | 2,131.78 |
| Other Income | 6.36 | 33.79 | 28.83 | 30.50 |
| PBDIT | 477.88 | 664.30 | 1,039.24 | 469.76 |
| Net Profit | 308.29 | 444.32 | 752.83 | 307.33 |
Balance Sheet
Mar'17
(In Rs Cr)
(In Rs Cr)
| Total Share Capital | 58.59 |
| Net Worth | 8,436.18 |
| Total Debt | 2,870.17 |
| Net Block | 3,211.62 |
| Investments | 1,681.95 |
| Total Assets | 11,306.35 |
Peers
Peer Comparison
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 553.50 | -0.20 | 608.55 | 433.15 | 132,802.61 |
| Cipla | 604.10 | 0.41 | 663.00 | 508.10 | 48,641.60 |
| Piramal Enter | 2523.05 | -0.64 | 3009.29 | 2279.05 | 45,564.39 |
| Cadila Health | 412.00 | 0.21 | 554.20 | 341.65 | 42,178.20 |
| Lupin | 894.25 | -0.51 | 1176.00 | 723.55 | 40,429.32 |
| More » | |||||
News on Peers & Sector
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
| Mar' 17 | Dec' 16 | Sep' 16 | Jun' 16 | |
| Promoter | 51.87 | 51.94 | 53.79 | 53.79 |
| Public (FII + DII) | 48.13 | 48.06 | 46.21 | 46.21 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
Mutual Funds Holding
| Scheme | No. of Shares |
| HDFC Equity Fund (G) | 4,803,146 |
| Aditya Birla Sun Life Frontline Equity Fund (G) | 4,274,319 |
| HDFC Top 100 Fund (G) | 3,339,811 |
| Reliance Equity Hybrid Fund (G) | 2,582,782 |
Company Information
REGISTERED OFFICE
Address
Plot No.2, Maitri Vihar, Ameerpet,,
City
Hyderabad
State
Telangana
Pin Code
500038
Tel. No.
040-23736370 040-66725000
Fax No.
040-23747340 040-67074059
Email:
Internet
REGISTRARS
Name
Karvy Computershare Private Ltd.
Address
Karvy Selenium Tower B Plot no. 31-32, Gachibowli Financial District Nanakramguda
City
Hyderabad - 500032
State
Telangana
Tel. No.
040-23001153
Fax No.
MANAGEMENT
Name
Designation
K Ragunathan
Non Executive Chairman
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
N Govindarajan
Managing Director
M Sivakumaran
Whole Time Director
M Madan Mohan Reddy
Whole Time Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT
APL Apollo Tubes Recommended on Jun 29th 2017
Recommended price 1,527.00 | Peak from reco 2587.00 69.37%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Aurobindo Pharm
Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 35,517.72 crore.
The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P Sarath Chandra Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, M Sitarama Murthy - Non Exe. & Ind. Director, Avnit Bimal Singh - Non Exe. & Ind. Director, Savita Mahajan - Addnl.Non Exe.Independent Director.
It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.
Its Registered office is at Plot No.2, Maitri Vihar, Ameerpet,, Hyderabad,Telangana - 500038.
Their Registrars are Karvy Computershare Private Ltd.
Quick Links for Aurobindo Pharma
Related Searches
Aurobindo Pharma Stock Price, Aurobindo Pharm Stock Quote, Aurobindo Pharm Results , Aurobindo Pharm News ..
More »
Follow moneycontrol
Explore Moneycontrol
Mutual Funds
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds |
Budget 2018 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Hyderabad | Online Shopping in India | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore
| Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Statement | Terms of Use | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
